
Casey Shea Hagopian
Examiner (ID: 14598, Phone: (571)272-6097 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617, 1615 |
| Total Applications | 833 |
| Issued Applications | 324 |
| Pending Applications | 170 |
| Abandoned Applications | 363 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7457479
[patent_doc_number] => 20040197368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents'
[patent_app_type] => new
[patent_app_number] => 10/475436
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1420
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197368.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475436 | Surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents | Apr 26, 2004 | Abandoned |
Array
(
[id] => 6925440
[patent_doc_number] => 20050238695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Lozenge for delivery of dextromethorphan'
[patent_app_type] => utility
[patent_app_number] => 10/833215
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238695.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833215 | Lozenge for delivery of dextromethorphan | Apr 26, 2004 | Abandoned |
Array
(
[id] => 6966068
[patent_doc_number] => 20050232965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque'
[patent_app_type] => utility
[patent_app_number] => 10/826058
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 57933
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826058 | Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque | Apr 14, 2004 | Abandoned |
Array
(
[id] => 7341394
[patent_doc_number] => 20040191239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Treatment and prevention of reactive oxygen metabolite-mediated cellular damage'
[patent_app_type] => new
[patent_app_number] => 10/819594
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11807
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10819594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/819594 | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage | Apr 6, 2004 | Abandoned |
Array
(
[id] => 7018893
[patent_doc_number] => 20050220912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Anti-inflammatory composition for treating pelvic endometriosis'
[patent_app_type] => utility
[patent_app_number] => 10/811839
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4097
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10811839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/811839 | Anti-inflammatory composition for treating pelvic endometriosis | Mar 29, 2004 | Abandoned |
Array
(
[id] => 7060623
[patent_doc_number] => 20050002983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Devices, methods, and compositions to prevent restenosis'
[patent_app_type] => utility
[patent_app_number] => 10/814490
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7326
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814490 | Devices, methods, and compositions to prevent restenosis | Mar 28, 2004 | Abandoned |
Array
(
[id] => 7181429
[patent_doc_number] => 20040202692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Implantable medical device and method for in situ selective modulation of agent delivery'
[patent_app_type] => new
[patent_app_number] => 10/810241
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7149
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20040202692.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810241 | Implantable medical device and method for in situ selective modulation of agent delivery | Mar 25, 2004 | Abandoned |
Array
(
[id] => 7171914
[patent_doc_number] => 20050203000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection'
[patent_app_type] => utility
[patent_app_number] => 10/809930
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4288
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809930
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809930 | Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection | Mar 25, 2004 | Abandoned |
Array
(
[id] => 7678075
[patent_doc_number] => 20040151751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Calcium phosphate/sulphate-based bone implant composition'
[patent_app_type] => new
[patent_app_number] => 10/476242
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1514
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476242 | Calcium phosphate/sulphate-based bone implant composition | Mar 24, 2004 | Abandoned |
Array
(
[id] => 5776276
[patent_doc_number] => 20060104916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Method and apparatus for enhanced size reduction of particles'
[patent_app_type] => utility
[patent_app_number] => 10/541909
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5413
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104916.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541909 | Method and apparatus for enhanced size reduction of particles | Feb 23, 2004 | Issued |
Array
(
[id] => 7456505
[patent_doc_number] => 20040197277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Chewable compositions with probiotic agents'
[patent_app_type] => new
[patent_app_number] => 10/785432
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7477
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785432 | Chewable compositions with probiotic agents | Feb 23, 2004 | Abandoned |
Array
(
[id] => 5608092
[patent_doc_number] => 20060269608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Pharmaceutical formulation'
[patent_app_type] => utility
[patent_app_number] => 10/543289
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5720
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269608.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543289
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543289 | Pharmaceutical formulation | Feb 1, 2004 | Issued |
Array
(
[id] => 8027463
[patent_doc_number] => 08142814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Method and apparatus for supercritical fluid assisted particle production'
[patent_app_type] => utility
[patent_app_number] => 10/541292
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4329
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/142/08142814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541292 | Method and apparatus for supercritical fluid assisted particle production | Jan 29, 2004 | Issued |
Array
(
[id] => 941010
[patent_doc_number] => 06969400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-29
[patent_title] => 'Synthetic implant with nonimmunogenicity coating'
[patent_app_type] => utility
[patent_app_number] => 10/766146
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 13543
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/969/06969400.pdf
[firstpage_image] =>[orig_patent_app_number] => 10766146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/766146 | Synthetic implant with nonimmunogenicity coating | Jan 26, 2004 | Issued |
Array
(
[id] => 6971235
[patent_doc_number] => 20050036945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Resorbable radiopaque markers and related medical implants'
[patent_app_type] => utility
[patent_app_number] => 10/762204
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3653
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20050036945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10762204
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/762204 | Resorbable radiopaque markers and related medical implants | Jan 19, 2004 | Abandoned |
Array
(
[id] => 7468154
[patent_doc_number] => 20040120977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Anti-inflammatory coatings for implantable medical devices and devices containing said coatings'
[patent_app_type] => new
[patent_app_number] => 10/732570
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7944
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20040120977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732570
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732570 | Anti-inflammatory coatings for implantable medical devices and devices containing said coatings | Dec 9, 2003 | Abandoned |
Array
(
[id] => 7217092
[patent_doc_number] => 20040071782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Ionophore antibiotic formulations'
[patent_app_type] => new
[patent_app_number] => 10/450079
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8554
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20040071782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450079 | Ionophore antibiotic formulations | Sep 28, 2003 | Abandoned |
Array
(
[id] => 9112586
[patent_doc_number] => 08568754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Low-emission formaldehyde donor preparations and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/663257
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4402
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10663257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/663257 | Low-emission formaldehyde donor preparations and use thereof | Sep 15, 2003 | Issued |
Array
(
[id] => 7314612
[patent_doc_number] => 20040034058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Novel pharmaceutical formulation suitable for nebulisation'
[patent_app_type] => new
[patent_app_number] => 10/311561
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2095
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311561 | Novel pharmaceutical formulation suitable for nebulisation | Aug 14, 2003 | Abandoned |
Array
(
[id] => 7018831
[patent_doc_number] => 20050220850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Topical anhydrous and ethanol-free ascomycin compositions'
[patent_app_type] => utility
[patent_app_number] => 10/523750
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3779
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523750 | Topical anhydrous and ethanol-free ascomycin compositions | Aug 12, 2003 | Abandoned |